EGASP: the human ENCODE Genome Annotation Assessment Project by Guigó, Roderic et al.
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
Genome Biology 2006, 7(Suppl 1):S2
Review
EGASP: the human ENCODE Genome Annotation Assessment
Project
Roderic Guigó*,1,11, Paul Flicek*,2, Josep F Abril*,1, Alexandre Reymond3,
Julien Lagarde1, France Denoeud1, Stylianos Antonarakis4, 
Michael Ashburner5,12, Vladimir B Bajic6,12, Ewan Birney2,11, 
Robert Castelo1, Eduardo Eyras1, Catherine Ucla4, Thomas R Gingeras7,12,
Jennifer Harrow8,11, Tim Hubbard8,11, Suzanna E Lewis9,12
and Martin G Reese*,10,12
Addresses: 1Centre de Regulació Genòmica, Institut Municipal d’Investigació Mèdica-Universitat Pompeu Fabra, E08003 Barcelona,
Catalonia, Spain. 2European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
3Center for Integrative Genomics, University of Lausanne, Switzerland. 4University of Geneva Medical School and University Hospitals of
Geneva, 1211 Geneva, Switzerland. 5Department of Genetics, University of Cambridge, Cambridge CB3 2EH, United Kingdom. 6South African
National Bioinformatics Institute (SANBI), University of Western Cape, Bellville 7535, South Africa. 7Affymetrix Inc., Santa Clara, California
95051, USA. 8Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom.
9Department of Molecular and Cellular Biology, University of California, Berkeley, California 94792, USA. 10Omicia Inc., Christie Ave.,
Emeryville, California 94608, USA. 11Member of the EGASP Organizing Committee. 12Member of the EGASP Advisory Board.
*These authors contributed equally to this work.
Correspondence: Roderic Guigo. Email: rguigo@imim.es; Martin G Reese. Email: mreese@omicia.com
Published: 7 August 2006
Genome Biology 2006, 7(Suppl 1):S2
The electronic version of this article is the complete one and can be 
found online at http://genomebiology.com/2006/7/S1/S2
© 2006 BioMed Central Ltd. 
Abstract
Background: We present the results of EGASP, a community experiment to assess the state-of-
the-art in genome annotation within the ENCODE regions, which span 1% of the human genome
sequence. The experiment had two major goals: the assessment of the accuracy of computational
methods to predict protein coding genes; and the overall assessment of the completeness of the
current human genome annotations as represented in the ENCODE regions. For the
computational prediction assessment, eighteen groups contributed gene predictions. We
evaluated these submissions against each other based on a ‘reference set’ of annotations
generated as part of the GENCODE project. These annotations were not available to the
prediction groups prior to the submission deadline, so that their predictions were blind and an
external advisory committee could perform a fair assessment.
Results: The best methods had at least one gene transcript correctly predicted for close to 70%
of the annotated genes. Nevertheless, the multiple transcript accuracy, taking into account
alternative splicing, reached only approximately 40% to 50% accuracy. At the coding nucleotide
level, the best programs reached an accuracy of 90% in both sensitivity and specificity. Programs
relying on mRNA and protein sequences were the most accurate in reproducing the manually
curated annotations. Experimental validation shows that only a very small percentage (3.2%) of
FreeBackground
During the first decade of the 21st century the sequencing of
whole genomes has become a routine biological practice. The
list of chordates with assembled genome sequences now
numbers nearly two dozen, while the total number of
sequenced bacteria, archea, and eukaryota is approaching
2,000. The genome sequence is said to be an organism’s
blueprint: the set of instructions dictating its biological
traits. In higher eukaryotic organisms, however, these traits
are apparently encoded by only a small fraction of the
genome sequence that is functional (possibly less than 5% in
the case of the human genome). The genes are a major
component of this functional sequence. While there is
growing evidence for many functional non-protein coding
RNA genes, such as miRNAs and snoRNAs, the largest and
best studied subset of the human genes comprise the protein
coding genes, genes specifying the amino acid sequence of
the proteins. Thus, locating the genes in a newly sequenced
genome is a first, essential step toward understanding how
the organism translates its genome sequence into biological
function. This paper focuses on the identification of protein
coding genes, if not otherwise noted.
Maybe to the surprise of many, five years after the first drafts
of the human genome sequence became available [1,2], and
nearly three years after the announcement of the completion
of the sequencing [3], a complete set of protein coding genes
encoded in the human genome does not exist. One reason for
the lack of a complete gene set is that an appropriately
rigorous standard has been set for the human genome: every
gene, exactly correct. And as shown in this paper, only very
few of the human genes seem to be missing from the
computational predictions, but the exact genomic structure of
these genes is estimated to be correct for only 50% of the
predicted genes. In other words, only very few protein coding
genes appear to have been totally missed today. Nevertheless,
getting the entire genomic structure of a protein coding gene
right is still a very difficult task, compounded by the large
amount of alternative splicing characterizing human genes.
Our assessment here tries to quantify the status of these
differences in the current human genome annotations and
computational prediction programs.
Automatic genome annotation methods
To date, accurate automatic annotation of the human genome
(and of other genomes with significant cDNA libraries)
strongly relies on an elaborate mapping of these known gene
sequences onto the genome sequence. This method of
genome annotation requires high quality and a nearly
complete set of cDNA sequences. Datasets trying to achieve
this goal, but are still works in progress, are the RefSeq
database [4] and those currently being produced by the
Mammalian Gene Collection (MGC) [5]. As the MGC project
- and similar efforts to deepen the coverage of the fraction of
the human genome being transcribed - continues, cDNA
mapping based gene identification methods are becoming
increasingly accurate. While few organisms will have the rich
cDNA libraries that are currently being developed for the
human genome, the availability of protein sequence data
from evolutionarily close relatives has been effectively used
in addition to cDNA data for automatic gene prediction
across many of the currently sequenced mammals. The most
commonly used annotation pipelines are the ENSEMBL
pipeline [6], the UCSC genome browser’s [7] Known Genes
(KG II) pipeline, and the Gnomon pipeline at the NCBI [8].
It remains unclear, however, what fraction of the low and
specifically expressed transcripts and of alternatively spliced
isoforms can be effectively recovered from cDNA libraries.
Additionally, orthologous proteins from other species may
not align genes that are rapidly evolving. For these reasons,
current cDNA and protein-based methods are likely to
provide an incomplete picture of the protein coding gene
content of the human genome. These methods will be less
accurate for genomes with fewer expressed sequences and
comparative options.
For automatic annotation of genomes without deep
expressed sequence libraries, any available cDNA or
expressed sequence tag (EST) based annotation is often
complemented by dual (or multiple) genome comparative
predictions. These predictions are obtained by means of
the analysis of the patterns of sequence conservation
between genome sequences of evolutionarily related
organisms. As examples, programs such SGP2 [9], SLAM
[10,11] and TWINSCAN [12,13] have contributed efficiently
to the annotation of a number of vertebrate genomes,
including mouse [14], rat [15], and chicken [16]. This type
of comparative-based automatic gene prediction can
produce highly accurate gene sets when the sequence of
related species is available, but few ESTs have been
sequenced, such as the case with the fungus Cryptococcus
neoformans [17].
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the selected 221 computationally predicted exons outside of the existing annotation could be
verified.
Conclusions: This is the first such experiment in human DNA, and we have followed the
standards established in a similar experiment, GASP1, in Drosophila melanogaster. We believe the
results presented here contribute to the value of ongoing large-scale annotation projects and should
guide further experimental methods when being scaled up to the entire human genome sequence.Occasionally, the so-called single genome ab initio
predictors - programs that use statistical sequence patterns,
such as the coding reading frame, codon usage or splice site
consensus sequences, for gene identification - are also used
to complement cDNA and comparative based methods.
When no genome exists at the appropriate phylogenetic
distance, and the cDNA or EST coverage of the transcrip-
tome is shallow, single genome ab initio predictions play an
important role in genome annotation, such as those
obtained, for example, by the programs GENSCAN [18] and
GENEID [19] in the initial annotation of the genome of the
fish Tetraodon nigroviridis [20].
In summary, despite substantial progress in the past decade
and the existence of highly accurate gene sets in a number of
organisms, current gene identification methods are, as yet,
not able to produce a complete catalogue of the set of protein
coding genes in higher eukaryotic genomes (see [21] for a
recent review).
Assessing the accuracy of automatic genome
annotation
Over the past quarter century, a large number of automated
gene prediction algorithms have been introduced, which can
be loosely grouped based on the general strategies described
above. These methods vary widely in the details of their
implementation and in the number and location of predicted
protein coding genes. Thus, the issue of evaluating the
accuracy of the predictive methods has been recurrent within
the field of computational gene prediction. The early work of
Burset and Guigó [22], and the subsequent analysis of Bajic
[23], Baldi et al. [24], Guigó et al. [25] , Rogic et al. [26] and
others, provide a framework - a set of metrics and a protocol -
to consistently evaluate gene prediction methods. Essentially,
a set of well-annotated sequences are used as a test set. The
gene prediction programs are run on these sequences, and
the predictions obtained are compared with the annotations.
A number of measures are computed to evaluate how well the
predictions reproduce the annotation. Typically, predictions
are evaluated at nucleotide, exon and gene levels. At all three
levels, two basic measures are computed: sensitivity, the
proportion of annotated features (nucleotide, exon, gene)
that have been predicted; and specificity, the proportion of
predicted features that is annotated. One problem with this
approach is that, until recently, very few large genomic
sequences were well annotated and only the coordinates of
the coding exons within a gene could be considered. More-
over, because methods did not exist to predict alternative
splicing, the test sets used to evaluate computational gene
predictions consisted of a few hundred short sequences
encoding single genes from which alternatively spliced
isoforms had been removed. This led to an oversimplification
of the problem and, in turn, to an overestimation of the real
accuracy of the programs [25]. Furthermore, many programs
were developed in-house and were, therefore, not accessible
for independent evaluation.
To address the problem of independent, objective assess-
ment of the state-of-the-art in automated tools and tech-
niques for annotating large contiguous genomic DNA
regions and eventually complete genomes, a first Genome
Annotation Assessment Project (GASP1) was organized in
1999 [27]. In many ways, GASP1 was set up similarly to
CASP (Critical Assessment of Techniques for Protein
Structure Prediction) [28]. In short, at GASP1, a genomic
region in Drosophila melanogaster, including auxiliary
training data, was provided to the community and gene
finding experts were invited to send the annotation files they
had generated to the organizers before a fixed deadline.
Then, a set of standards were developed to evaluate submis-
sions against the later published annotations [29], which
had been withheld until after the submission stage. Next, the
evaluation results were assessed by an independent advisory
team and publicly presented at a workshop at the Intelligent
Systems in Molecular Biology (ISMB) 1999 meeting. This
community experiment was then published as a collection of
methods and evaluation papers in Genome Research [27].
The ENCODE Genome Annotation Assessment
Project
Inspired by GASP1, and within the context of the
ENCyclopedia Of DNA Elements (ENCODE) project, we
organized the ENCODE GASP (EGASP) community experi-
ment, which followed closely the model of its predecessor,
GASP1 [27]. The ENCODE project was launched two years
ago by the National Human Genome Research Institute
(NHGRI) with the aim of identifying all functional elements
in the genome sequence through the collaborative effort of
computational and laboratory-based scientists [30]. The
pilot phase of the project is focused on a selected 30 Mb of
sequence within 44 selected regions (Table 1) across the
human genome, which represents approximately 1% of the
genome sequence.
Within the ENCODE project, the GENCODE consortium
[31] was set up. This group, in collaboration with the
HAVANA team [32] at the Sanger Institute, has produced a
high quality annotation of the gene content of the ENCODE
regions through a combined manual, computational and
experimental strategy [33]. The EGASP experiment was
organized with the main goal of evaluating how well auto-
matic methods are able to reproduce this annotation
produced by GENCODE. A second goal of EGASP was to
assess the completeness of the GENCODE annotation and,
in this regard, EGASP was designed such that, in a follow-up
step, a number of computational gene predictions not
included in GENCODE were tested experimentally.
In what follows, we first describe the organization and
structure of the EGASP experiment. We then present the
results of the evaluation of the submitted predictions against
the GENCODE annotation, and finally we present the results
of the experimental verification of the novel predictions.
http://genomebiology.com/2006/7/S1/S2 Genome Biology 2006, Volume 7, Supplement 1, Article S2 Guigó et al. S2.3
Genome Biology 2006, 7(Suppl 1):S2
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
hThe EGASP experiment
Data: the benchmark sequence of 44 selected ENCODE regions
Description of the sequence
The 44 ENCODE regions represent 30 Mb (approximately
1%) of the human genome [30]. Approximately half of the
sequence corresponds to a set of 14 manually selected
regions including well-studied genes and for which a
significant amount of prior comparative sequence data was
available. The remaining 30 genomic regions were chosen
based on a stratified random sampling based on two
measures: gene density (from previous annotations) and
non-exonic conservation with the mouse genome sequence.
Briefly, each portion of the human genome sequence was
classified as high, medium, or low if it fell in the top 20%, the
middle 30%, or the bottom 50%, respectively, of the above
two measures. Several 500 kb sequences were chosen from
each of the nine classifications created by this stratification
procedure.
Table 1 lists the 44 selected sequences within the ENCODE
region and classifies them based on random/manual
selection, previously known gene density and non-exonic
conservation to the mouse genome. It also describes the size
differences between the sequences. Information about the
criteria used to select the regions and their characteristics
can be found on the ENCODE website [34]. The sequences of
the ENCODE regions (as well as multiple functional
annotations) can be downloaded from the UCSC ENCODE
browser [35].
We defined the sequences used for the EGASP experimental
evaluation by taking advantage of the prior work of the
HAVANA team [32], which had previously comprehensively
annotated and released annotation for several human
chromosomes [36-42]. Updated annotation for the 13
ENCODE regions on these chromosomes was released in
January 2005 as a ‘training’ set for the EGASP experiment.
The manual annotation of the other 31 ENCODE regions was
held back from release until after the automated gene
predictions had been received. The 31 EGASP test regions
represent a total of 21.6 million base-pairs (bp) of sequence.
Further information is available at the GENCODE website
[31].
The reference gene set: the GENCODE annotations
The ENCODE regions had been subjected to an exhaustive
annotation strategy prior to EGASP by the HAVANA team.
In short, the annotators initially build coding transcripts
manually based on alignments of known mRNA, EST and
protein sequences to the human genome. The initial gene
map delineated in this way was then experimentally refined
through reverse transcription (RT)-PCR and rapid amplifi-
cation of cDNA ends (RACE), which essentially confirmed the
existence of the mRNA sequences of the hypothesized genes.
Finally, the initial annotation was refined by the annotators
based on these experimental results. While the initial
annotation by the HAVANA team is augmented by some
experimentally verified ab initio and dual-genome gene
predictions without a priori transcript sequence support,
these constitute a marginal fraction of the entire GENCODE
annotation set. The strategy is described in detail elsewhere in
this issue [33]. We used this final annotation as the reference
set for EGASP, and refer to it as the GENCODE annotation.
The protein coding GENCODE annotation for all 44
ENCODE regions consists of 2,471 total transcripts repre-
senting 434 unique protein coding gene loci. There are 1,097
coding transcripts that code for 993 unique proteins. The
S2.4 Genome Biology 2006, Volume 7, Supplement 1, Article S2 Guigó et al. http://genomebiology.com/2006/7/S1/S2
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Table 1
The 44 selected sequences within the ENCODE region
Random picks
Mouse homology
Sequence Manual  Gene 
set picks Low Medium High density
Training ENm006 ENr132 ENr231 ENr333  High
ENr232 ENr334
ENm004 - ENr222 ENr323 Medium
ENr223 ENr324
- ENr111 - - Low
ENr114
Test ENm002 ENr131 ENr233 ENr331  High
ENm005 ENr133 ENr332
ENm007
ENm008
ENm009
ENm010
ENm011
ENm001 ENr121 ENr221 ENr321 Medium
ENm003 ENr122 ENr322
ENm012 ENr123
ENm013
ENm014
- ENr112  ENr211 ENr311 Low
ENr113 ENr212 ENr312
ENr213 ENr313
ENCODE sequences were assigned to either the training or the test set
based on annotation data availability (see the section ‘The EGASP
experiment’). For the performance evaluation, only the test set sequences
were used. The numeric code for the randomly picked sequence names
correspond to the non-exonic conservation with the mouse genome, the
density of previously identified genes, and the sequence number,
respectively; numbers vary from 1 (low), to 3 (high). Manually selected
sequences range in size from 500 kbp to 2 Mbp, while random regions are
500 kbp. The selection and stratification criteria for all the sequences is
described at the ENCODE project web site [34].annotation identifies 5.7 total transcripts per locus, with an
average of 2.52 coding transcripts. Of the 434 coding loci,
393 contain multi-exon transcripts. In line with earlier
estimates [43], 86% of the multi-exon loci exhibit alternative
splicing in either the coding or non-coding transcripts. Sixty
percent of multi-exon loci have alternative coding
transcripts. See [33] in this issue for additional details.
Incomplete annotation
The GENCODE annotation includes incomplete genes and
transcripts. These are caused both by the truncation of some
features at the end of the ENCODE regions and by transcript
annotations that may be incomplete due to lack of evidence.
In the rare case that an exon crossed an ENCODE region
boundary, the exon was truncated at the ENCODE region
boundary in both the annotations and the predictions to
ensure that the nucleotide level evaluation statistics were
computed correctly (see Materials and methods).
EGASP: a community experiment
To determine an automatic method’s ability to reproduce the
GENCODE annotation, we organized EGASP in the follow-
ing way: In January 2005, the GENCODE annotation for 13
of the 44 ENCODE regions (the ‘training regions’ defined
above) was publicly released. With the release of this
annotation, EGASP was officially announced: gene and other
DNA feature prediction groups world-wide were asked to
submit genome annotations on the remaining 31 ENCODE
regions, for which the GENCODE annotations would not be
released until the deadline for submission expired. Partici-
pating groups had access to the annotation of the 13 training
regions, as well as to the sequences and all additional
publicly available data for all 44 ENCODE regions. No other
pre-defined and pre-selected auxiliary data, such as cDNA
databases, EST sequences or other genome alignments, were
given to the submitters. However, many of the 31 test
regions had been previously and extensively annotated by
other groups. For example, ENm001, the greater cystic
fibrosis transmembrane receptor (CFTR) region, has been
extensively studied [44].
Participants were asked to submit their genome annotations
on the 31 ENCODE test regions, using whatever methods and
data were available to them. To be able to better compare
different DNA feature prediction methods, we predefined the
following prediction categories and asked the submitters to
indicate in which category they were submitting: methods
using any type of available information; single-genome ab
initio methods; EST-, mRNA-, and protein-based methods;
dual- or multiple-genome based methods; methods predic-
ting unusual genes (non-canonical splicing, short intron-less
genes, and so on); and exon-only predictions.
Finally, we allowed an extra category (category 7) for methods
predicting other annotation features, including pseudogenes
and promoters. Bajic et al. [45] have conducted a compre-
hensive evaluation of the promoter predictions and see
Zheng and Gerstein [46] for a paper on pseudogenes.
A web server (Figure 1) [47] was set up to collect all the
submissions and each group was able to submit predictions
for more than one category. The submitted predictions, as
well as the GENCODE annotations for the test sequence set,
were kept confidential until the submission deadline on 15
April 2005. The format for submissions was the Gene
Transfer Format (GTF) [48]. An advisory committee (Table 2)
was formed to oversee the submission and evaluation
processes and provide advice for the evaluation.
By the submission deadline on 15 April 2005, 18 groups had
submitted 30 prediction sets (Table 3). All the submitted
predictions together with the annotations are available
through the GencodeDB Genome Browser (Figure 2) [49], as
well as through the UCSC Genome Browser (‘EGASP’
tracks). They can also be downloaded from the ftp server as
plain text GTF files [50].
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Figure 1
A screenshot of the EGASP submission server [47]. The server was user-
authenticated in order to keep the submitted predictions in private
before the EGASP workshop. Initially, there were eight suggested
submission categories. However, after the workshop, category 5 was not
used at all and removed. Promoter and pseudogene predictions from
category 8 were then kept as a new category 7, which is not analyzed in
this paper (see [45] instead).Predictions were compared with the reference set
GENCODE annotations and assessed by members of the
advisory and organizing committees (Table 2), all selected as
independent experts in this field. The results of this
assessment were presented at a workshop that took place at
the Wellcome Trust Genome Campus in Hinxton, UK, on 6
and 7 May 2005. The advisory and organizing committees
met on 4 May for a pre-evaluation of the predictions, and to
determine a number of summary statistics. Each of the
submitting groups was invited to present their methods and
submissions at the workshop with a focus on what went right
and what went wrong. In total, 16 groups were represented
at the workshop. The final prediction evaluation results from
the workshop are discussed in the next section.
Results
The evaluation of the predictions against the annotation
The protocol to evaluate the predictions
The main goal of the EGASP experiment was to evaluate the
ability of automatic methods of genome annotation to repro-
duce the manual and experimental annotation of the
ENCODE regions described above. By this standard, a
perfect prediction strategy would produce annotation com-
pletely consistent with the GENCODE annotation.
For the purposes of evaluating the submitted predictions, we
considered only the results for the 31 test ENCODE regions,
which were the ‘blinded’ regions for which no GENCODE
annotations were available during the submission phase.
Potential biases introduced by this restriction will be
addressed below. The statistics reported are computed
globally for the test region, which means that the total
number of prediction successes and failures for all 31 regions
are compared directly to the total number of annotated
exons, transcripts and genes for all 31 regions.
We evaluated each set of submitted predictions at four
distinct levels: nucleotide accuracy, exon accuracy, trans-
cript accuracy, and gene accuracy. At the earlier GASP1
workshop, transcript accuracy levels were not assessed due
to the limited transcript information and the lower levels of
alternatively spliced transcripts in Drosophila melanogaster
[27]. For this study we also made a distinction between the
statistics calculated for the coding portions of the mRNA
S2.6 Genome Biology 2006, Volume 7, Supplement 1, Article S2 Guigó et al. http://genomebiology.com/2006/7/S1/S2
Genome Biology 2006, 7(Suppl 1):S2
Table 2
EGASP organizing and advisory committees
Organizers Advisory board
Jennifer Ashurst (Wellcome Trust Sanger Institute) Michael Ashburner (Cambridge University)
Ewan Birney (European Bionformatics Institute) Vladimir B Bajic (Institute for Infocomm Research)
Peter Good (National Human Genome Research Institute) Tom Gingeras (Affymetrix, Inc.)
Roderic Guigó (Institut Municipal d’Investigació Mèdica) Suzanna Lewis (Berkeley)
Tim Hubbard (Wellcome Trust Sanger Institute) Martin Reese (Omicia, Inc.)
Figure 2
The GencodeDB Genome Browser. A screenshot of the GencodeDB
Genome Browser [49], displaying the annotation features on 100 Kbp
from the ENm001 region (chr7: 116,074,892-116,174,891). The
annotations along with the predicted genes by each submitted method
were made publicly available together with further experimental evidence,
such as TARs/transfrags.
 http://genomebiology.com/2006/7/S1/S2 Genome Biology 2006, Volume 7, Supplement 1, Article S2 Guigó et al. S2.7
Genome Biology 2006, 7(Suppl 1):S2
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
Table 3
Summary of programs used to determine predictions submitted for each EGASP category
Submission category Program Affiliation Reference
1 (AUGUSTUS-any) AUGUSTUS Georg-August-Universität, Göttingen [58]
2 (AUGUSTUS-abinit)
3 (AUGUSTUS-EST)
4 (AUGUSTUS-dual)
1 FGENESH++ Softberry Inc. [56]
1 JIGSAW The Institute for Genomic Research (TIGR) [59]
1 (PAIRAGON-any) PAIRAGON and NSCAN_EST Washington University, Saint Louis (WUSTL) [57]
3 (PAIRAGON+NSCAN_EST)
2 GENEMARK.hmm Georgia Institute of Technology [60]
2 GENEZILLA TIGR [81]
3 ACEVIEW National Center for Biotechnology Information (NCBI) [52]
3 ENSEMBL The Wellcome Trust Sanger Institute (WTSI) and  [64]
European Bioinformatics Institute (EBI)
3 EXOGEAN Ecole Normale Superieure, Paris [62]
3 EXONHUNTER University of Waterloo [63]
4 ACESCAN* Salk Institute [82]
4 DOGFISH-C WTSI [67]
4 NSCAN WUSTL [57]
4 SAGA University of California at Berkeley [66]
4 MARS WUSTL - EBI [65]
5 GENEID-U12 Institut Municipal d’Investigació  –
5 SGP2-U12 Mèdica, Barcelona
6 ASPIC† Università degli Studi di Milano [83]
6 (AUGUSTUS-exon) AUGUSTUS Georg-August-Universität, Göttingen [58]
6 CSTMINER‡ Università degli Studi di Milano [84]
6 DOGFISH-C-E§ WTSI [67]
6 SPIDA EBI [85]
6 UNCOVER§ Duke University [86]
1 CCDSGene UCSC tracks [7] [55]
1 KNOWNGene [54]
1 REFSEQ (REFGene) [4]
2 GENEID [19]
2 GENSCAN [18]
3 ACEMBLY [52]
3 ECGene [53]
3 ENSEMBL (ENSGene) [6]
3 MGCGene [5]
4 SGP2 [9]
4 TWINSCAN [12,13]
- CODING  20050607 GENCODE  annotation [33]
- GENES  20050607
A complete listing of the number of features for each sequence obtained by each method is available at the Supplementary material web page [51]. *The
ACESCAN group submitted results only for the training set and, therefore, has not been evaluated. †ASPIC only provided results for the training regions
and, therefore, has not been evaluated. Moreover, ASPIC submitted only intron annotations and should be considered in category 6. ‡CSTMINER
predicts coding regions but does not provide strand information. §DOGFISH-C-E and UNCOVER predict only novel exons; this makes it difficult to
compare these methods with the others in the same category.transcripts (coding sequence (CDS) evaluations) and the
mRNA transcripts as a whole (mRNA evaluations).
For each of the four levels, we calculated the sensitivity and
specificity of the predictions as defined below. In some
cases, we have also computed other standard measures
previously used in the gene finding literature (see [22-27]).
Many additional measures of accuracy have been computed
on the EGASP predictions, and they are available through
the Supplementary Material web page [51].
Non-EGASP entries
To compare the EGASP results to existing community stan-
dards, we also evaluated the performance of 11 gene annota-
tion tracks published in the UCSC Browser [7] just before the
start of the EGASP workshop. These tracks included two
single genome ab initio prediction methods (GENSCAN [18]
and GENEID [19]) and two dual-genome prediction methods
(TWINSCAN [12,13] and SGP2 [9]). We also considered four
methods we classified as using expressed sequence (ENSGENE
[6], ACEMBLY [52], MGCGENES [5], and ECGENE [53])
and three we classified as using any information (UCSC
‘KNOWN’ genes [54], REFSEQ genes [4], and CCDSGENES
[55]).
Measures used for evaluating predictions: definitions
Nucleotide level accuracy is a comparison of the annotated
nucleotides with the predicted nucleotides. Individual
nucleotides appearing in more than one transcript in either
the annotation or the predictions are considered only once
for the nucleotide level statistics (Figure 3a). Nucleotide
predictions must be on the same strand as the annotations to
be counted as correct. At the nucleotide level, sensitivity (Sn)
is the proportion of annotated nucleotides (as being coding
or part of an mRNA molecule) that is correctly predicted,
and specificity (Sp) the proportion of predicted nucleotides
(as being coding or part of an mRNA molecule) that is so
annotated. As a summary measure, we have computed either
the simple average of these two measures, or the correlation
coefficient between the annotated and the predicted
nucleotides (see [22-27]).
The exon level accuracy is calculated with the requirement
that an exon in the prediction must have identical start and
end coordinates as an exon in the annotation to be counted
correct. Only the unique exons in each set are considered
(see Figure 3b for a graphical example of how unique exons
are collected from both the annotation and prediction sets;
also see [22-27] for more details on these definitions). At the
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Figure 3
Gene Feature Projection for evaluation. The process of projecting genic features into unique nucleotide and exon coordinates in order to compute the
accuracy values (see text for details).
EVALUATION AT NUCLEOTIDE LEVEL EVALUATION AT EXON LEVEL (a) (b)
ANNOTATION SET PREDICTION SET TRUE POSITIVES FALSE POSITIVES FALSE NEGATIVESexon level, sensitivity is computed as the proportion of
annotated exons correctly predicted, and specificity as the
proportion of predicted exons that is annotated. As a
summary measure, we have computed the average of these
two measures. In addition, we have computed ‘missing
exons’ (MEs), the proportion of annotated exons totally
missed by the predictions (that is, there is no overlap by a
predicted exon by at least 1 bp), and ‘wrong exons’ (WEs),
the proportion of predicted exons not overlapping annotated
exons by at least 1 bp. A subset of predicted exons falling in
regions annotated as intergenic have been tested experi-
mentally (see the section ‘The experimental test of unanno-
tated predictions’ below for details). Nucleotide and exon
level accuracy are calculated for the CDS evaluation and for
the mRNA evaluation. Comparison of the results of these
evaluation strategies highlights the differences for those
programs that attempt to predict untranslated regions
(UTRs) of genes.
The transcript and gene level accuracy measures are more
stringent. We consider a transcript accurately predicted for
the CDS evaluation if the beginning and end of translation
are correctly annotated and each of the 5’ and 3’ splice sites
for the coding exons are correct. Similarly, for the mRNA
evaluation, a transcript is counted correct if all of the exons
from the start of transcription to the end of transcription are
correctly predicted. Thus, at the transcript level, sensitivity
is the proportion of annotated transcripts that is correctly
predicted, and specificity is the proportion of predicted
transcripts that is correct. A gene is counted correct if at
least one transcript in the locus is correct as defined above,
and sensitivity and specificity are defined accordingly. Using
these definitions, transcript accuracy is the most stringent
measure for both the CDS evaluation and for the mRNA
evaluation (Figure 4).
The accuracy of the prediction methods must be considered
in the context of the annotation, which contains a significant
fraction of incomplete transcripts. In the case of an
incomplete transcript, we made the distinction that if a
prediction is completely consistent with the annotation, it
will be counted correct. For example, if the annotation
contains an incomplete transcript with three exons and a
prediction method includes a transcript with these exons
plus an additional exon, we consider the prediction to be
completely consistent with the annotation and count it as a
correct prediction. For the CDS evaluation, if the annotation
contains a complete coding transcript, it must be predicted
correctly and no additional exons are allowed (Figure 4).
Global results and trends
The evaluation statistics discussed above for the CDS
evaluation are provided in Tables 4 and 5 and for the mRNA
evaluation in Table 6, which only lists methods that predict
full mRNA transcripts. Figures 5-8 display the results for the
CDS evaluation at the nucleotide, exon, transcript and gene
levels. Values are given for programs in categories 1 to 4 (see
previous section and Table 3), which constitute the bulk of
the submitted predictions. The accuracies of the programs in
other categories are often not strictly comparable and,
therefore, not shown in these figures. They are, however,
given in the Supplementary material [51]. The top panel in
Figures 5-8 is a dotplot of sensitivity versus specificity,
where each dot represents the performance of one program.
The bottom panel includes a boxplot for each program
displaying the average of sensitivity and specificity (that is,
(Sn + Sp)/2) for the given program on each of 27 test
sequences (see Materials and methods). Four test sequences
(ENr112, ENr113, ENr311, ENr313) were removed from the
original set of 31 because they did not contain any annotated
protein coding genes and, therefore, sensitivity and
specificity could not be computed for them. The dotplot
intends to capture the global balance between sensitivity and
specificity for each program, while the boxplots provide the
dispersion of the accuracy of each program predictions
across test sequences. At similar average accuracies,
programs providing more consistent predictions across
sequences may be preferable since their behavior can be
better anticipated.
No annotation strategy produced perfect predictions, but
several clear trends emerged from the evaluations and are
summarized here.
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Figure 4
Gene transcript evaluation. Computing sensitivity and specificity at
transcript level: (a) complete transcript annotation; (b) incomplete
transcript annotation. Transcripts marked with an asterisk are considered
‘consistent with the annotation’ and will be scored as correct.
Annotation
Prediction
Annotation unique transcripts:4
Prediction unique transcripts:5
Annotation unique genes:3
Prediction unique genes:2
Transcript sensitivity =75%(3/4)
Transcript specificity=60%(3/5)
Gene sensitivity =67%(2/3)
Gene specificity =100%(2/2)
*
*
Gene B Gene A Gene C
Gene a Geneb
*
Annotation
Prediction
*
*
*
Gene B Gene A Gene C
Gene a Gene b
(a)
(b)
Annotation unique transcripts:4
Prediction unique transcripts:5
Annotation unique genes:3
Prediction unique genes:2
Transcript sensitivity =50%(2/4)
Transcript specificity=60%(3/5)
Gene sensitivity =33%(1/3)
Gene specificity =50%(1/2)S2.10 Genome Biology 2006, Volume 7, Supplement 1, Article S2 Guigó et al. http://genomebiology.com/2006/7/S1/S2
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Table 4
CDS assessment: summary of accuracy measures for CDS features at the nucleotide and exon levels
Nucleotide Exon
NSn NSp N CC ESn ESp ME WE
Category 1
AUGUSTUS-any 94.42% 82.43% 0.88 74.67% 76.76% 8.25% 16.29%
FGENESH++ 91.09% 76.89% 0.83 75.18% 69.31% 9.73% 24.64%
JIGSAW 94.56% 92.19% 0.93 80.61% 89.33% 6.22% 7.78%
PAIRAGON-any 87.77% 92.78% 0.90 76.85% 88.91% 11.18% 6.82%
Category 2
AUGUSTUS-abinit 78.65% 75.29% 0.76 52.39% 62.93% 29.09% 24.82%
GENEMARK.hmm-A 78.43% 37.97% 0.53 50.58% 29.01% 27.86% 63.27%
GENEMARK.hmm-B 76.09% 62.94% 0.69 48.15% 47.25% 31.77% 40.68%
GENEZILLA 87.56% 50.93% 0.66 62.08% 50.25% 19.14% 41.93%
Category 3
ACEVIEW 90.94% 79.14% 0.84 85.75% 56.98% 4.38% 16.69%
AUGUSTUS-EST 92.62% 83.45% 0.88 74.10% 77.40% 9.01% 15.61%
ENSEMBL 90.18% 92.02% 0.91 77.53% 82.65% 9.99% 9.22%
EXOGEAN 84.18% 94.33% 0.89 79.34% 83.45% 9.88% 5.06%
EXONHUNTER 90.46% 59.67% 0.73 64.44% 41.77% 14.29% 50.94%
PAIRAGON+NSCAN_EST 87.56% 92.77% 0.90 76.63% 88.95% 11.51% 6.85%
Category 4
AUGUSTUS-dual 88.86% 80.15% 0.84 63.06% 69.14% 16.82% 19.60%
DOGFISH 64.81% 88.24% 0.74 53.11% 77.34% 32.67% 11.70%
MARS 84.25% 74.13% 0.78 65.56% 61.65% 20.26% 26.10%
NSCAN 85.38% 89.02% 0.87 67.66% 82.05% 17.11% 10.93%
SAGA 52.54% 81.39% 0.65 38.82% 50.73% 40.48% 27.85%
UCSC Tracks
ACEMBLY  96.43% 58.47% 0.74 84.66% 38.32% 2.71% 28.55%
CCDSgene  56.87% 99.52% 0.75 51.95% 97.75% 40.38% 0.27%
ECgene  96.36% 47.30% 0.66 86.22% 35.08% 2.64% 45.92%
ENSgene  91.39% 91.92% 0.92 77.71% 82.39% 9.80% 9.21%
GENEID  76.77% 76.48% 0.76 53.84% 61.08% 27.86% 27.26%
GENSCAN  84.17% 60.60% 0.71 58.65% 46.37% 19.50% 42.91%
KNOWNgene  89.10% 93.61% 0.91 78.11% 82.28% 10.27% 4.30%
MGCgene  44.06% 97.56% 0.65 42.95% 93.61% 49.28% 2.68%
REFgene  85.34% 98.50% 0.92 73.23% 94.67% 15.38% 1.22%
SGPgene  82.81% 82.20% 0.82 60.56% 65.16% 19.36% 22.85%
TWINSCAN  78.16% 84.59% 0.81 58.43% 73.11% 24.64% 16.30%
CC, correlation coefficient.http://genomebiology.com/2006/7/S1/S2 Genome Biology 2006, Volume 7, Supplement 1, Article S2 Guigó et al. S2.11
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Table 5
CDS assessment at the transcript and gene levels
Transcript Gene
TSn TSp GSn GSp Ratio CDS/UTR
Category 1
AUGUSTUS-any 22.65% 35.59% 47.97% 35.59% 100.00%
FGENESH++ 36.21% 41.61% 69.93% 42.09% 78.25%
JIGSAW 34.05% 65.95% 72.64% 65.95% 100.00%
PAIRAGON-any 39.29% 60.34% 69.59% 61.32% 62.92%
Category 2
AUGUSTUS-abinit 11.09% 17.22% 24.32% 17.22% 100.00%
GENEMARK.hmm-A 6.93% 3.24% 15.20% 3.24% 100.00%
GENEMARK.hmm-B 7.70% 7.91% 16.89% 7.91% 100.00%
GENEZILLA 9.09% 8.84% 19.59% 8.84% 100.00%
Category 3
ACEVIEW 44.68% 19.31% 63.51% 48.65% 49.15%
AUGUSTUS-EST 22.50% 37.01% 47.64% 37.01% 100.00%
ENSEMBL 39.75% 54.64% 71.62% 67.32% 65.77%
EXOGEAN 42.53% 52.44% 63.18% 80.82% 59.60%
EXONHUNTER 10.48% 6.33% 21.96% 6.33% 100.00%
PAIRAGON+NSCAN_EST 39.29% 60.64% 69.59% 61.71% 62.89%
Category 4
AUGUSTUS-dual 12.33% 18.64% 26.01% 18.64% 100.00%
DOGFISH 5.08% 14.61% 10.81% 14.61% 100.00%
MARS 15.87% 15.11% 33.45% 24.94% 100.00%
NSCAN 16.95% 36.71% 35.47% 36.71% 79.80%
SAGA 2.16% 3.44% 4.39% 3.44% 100.00%
UCSC Tracks
ACEMBLY  33.90% 7.96% 54.39% 21.24% 48.56%
CCDSgene  28.97% 85.58% 55.41% 89.39% 100.00%
ECgene  56.86% 8.84% 79.05% 12.42% 46.11%
ENSgene  40.52% 54.09% 73.99% 68.30% 65.62%
GENEID  4.78% 8.78% 10.47% 8.78% 100.00%
GENSCAN  7.40% 10.13% 15.54% 10.13% 100.00%
KNOWNgene  43.45% 46.93% 77.03% 72.79% 60.03%
MGCgene  23.73% 78.24% 49.32% 82.56% 63.43%
REFgene  41.91% 75.21% 77.03% 82.76% 61.82%
SGPgene  8.17% 12.59% 17.57% 12.59% 100.00%
TWINSCAN  10.63% 20.25% 22.30% 20.25% 100.00%
The ratio CDS/UTR was obtained by summing up all the coding exons’ lengths and dividing by the sum of all the exons’ lengths. The ratio CDS/UTR for
the annotations is 36.78%.The prediction methods that used expressed sequence infor-
mation (category 3) and those that used any information
(category 1 prediction methods often used expressed sequence
information) were generally the most accurate for all
measures.
The three best category 4 dual-genome methods (NSCAN,
MARS, and AUGUSTUS-dual) were more accurate than the
category 2 single genome ab initio prediction methods.
At the nucleotide level, JIGSAW and ENSEMBL both
achieved greater than 90% for both sensitivity and specificity
for the CDS evaluation, while several other methods scored
greater than 80% for both sensitivity and specificity on the
same measure, including the NSCAN and AUGUSTUS dual-
genome methods (Figure 5). For the mRNA evaluation,
ACEVIEW reached 88% sensitivity at 79% specificity, while
ENSEMBL and EXOGEAN were more specific with 95% and
94%, respectively, but at much lower sensitivities of 61% and
60%, respectively.
At the exon level, the most accurate predictor of coding
exons was JIGSAW with greater than 80% sensitivity while
maintaining nearly 90% specificity. ACEVIEW was the most
sensitive prediction method for all exons (coding and non-
coding) with greater than 85% (CDS) and 64% (mRNA) exon
sensitivity while still being reasonably specific (Figure 6).
At the transcript level, no prediction method correctly
identified greater than 45% of the coding transcripts exactly
(see sensitivity in Figure 7).
At the gene level, using the measure of averaged sensitivity
and specificity, the most accurate gene level predictions in
the CDS evaluation were produced by EXOGEAN followed
by JIGSAW and ENSEMBL. JIGSAW and ENSEMBL were
the only two methods with greater than 70% gene level
sensitivity. Of the two, JIGSAW was slightly more sensitive,
while ENSEMBL was slightly more specific. EXOGEAN’s
specificity was higher than 80%, which is more than 13%
higher than any other program (Figure 8; Table 5).
Relatively few prediction methods are able to predict
multiple transcripts per gene locus. These include four
expressed sequence methods from category 3
(PAIRAGON+NSCAN_EST, EXOGEAN, ACEVIEW, and
ENSEMBL), FGENESH++ and PAIRAGON-any from
category 1, and MARS from category 4.
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Table 6 
mRNA assessment: summary of accuracy measures of mRNA features at the nucleotide and exon levels
Nucleotide Exon
NSn NSp N CC ESn ESp ME WE
Category 1
FGENESH++ 48.87% 81.16% 0.62 35.84% 58.41% 19.20% 22.84%
PAIRAGON-any 56.31% 89.36% 0.70 41.23% 74.93% 15.83% 7.95%
Category 3
ACEVIEW 88.08% 79.47% 0.83 64.16% 61.18% 3.60% 10.41%
ENSEMBL 61.61% 95.26% 0.76 41.61% 73.41% 12.84% 7.09%
EXOGEAN 60.58% 94.73% 0.75 48.87% 76.29% 10.38% 4.16%
PAIRAGON+NSCAN_EST 56.22% 89.35% 0.70 41.11% 74.98% 16.06% 7.98%
Category 4
NSCAN 39.55% 78.69% 0.55 32.41% 65.25% 26.10% 14.69%
UCSC Tracks
ACEMBLY  91.94% 53.98% 0.70 65.51% 44.28% 2.15% 18.26%
ECgene  93.00% 38.68% 0.59 58.17% 34.83% 1.81% 34.31%
ENSgene  62.43% 95.27% 0.77 41.71% 72.65% 12.62% 7.10%
KNOWNgene  65.74% 91.82% 0.77 43.84% 74.57% 13.58% 2.74%
MGCgene  29.17% 96.73% 0.53 21.21% 74.10% 47.16% 2.22%
REFgene  57.51% 97.07% 0.74 38.35% 83.51% 19.28% 0.91%
Only programs that submitted 5’ or 3’ UTR exon annotations besides the CDS parts of exons are shown. CC, correlation coefficient.http://genomebiology.com/2006/7/S1/S2 Genome Biology 2006, Volume 7, Supplement 1, Article S2 Guigó et al. S2.13
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Figure 5
Gene Prediction Accuracy at the nucleotide level: Sensitivity versus specificity. Top panel: dotplot for sensitivity versus specificity at the nucleotide level
for CDS evaluation. Each dot represents the overall value for each program on the 31 test sequences. Bottom panel: boxplots of the average sensitivity
and specificity ((Sn + Sp)/2) for each program. Each dot corresponds to the average in each of the test sequences for which a GENCODE annotation
existed (27 out of 31 sequences).
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Figure 6
Gene Prediction Accuracy at the exon level: Sensitivity versus specificity. Top panel: dotplot for sensitivity versus specificity at the exon level for CDS
evaluation. Each dot represents the overall value for each program on the 31 test sequences. Bottom panel: boxplots of the average sensitivity and
specificity for each program. Each dot corresponds to the average in each of the test sequences for which GENCODE annotation existed.
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Figure 7
Gene Prediction Accuracy at the transcript level: Sensitivity versus specificity. Top panel: dotplot for sensitivity versus specificity at the transcript level
for CDS evaluation. Each dot represents the overall value for each program on the 31 test sequences. Bottom panel: boxplots of the average sensitivity
and specificity for each program. Each dot corresponds to the average in each of the test sequences for which GENCODE annotation existed.
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Figure 8
Gene Prediction Accuracy at the gene level: Sensitivity versus specificity. Top panel: dotplot for sensitivity versus specificity at the gene level for CDS
evaluation. Each dot represents the overall value for each program on the 31 test sequences. Bottom panel: boxplots of the average sensitivity and
specificity for each program. Each dot corresponds to the average in each of the test sequences for which GENCODE annotation existed.
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Expressed sequencesMost of the methods predict genes that, on average, have
fewer coding exons per gene than the GENCODE annotation
(Figure 9). The only exceptions to this observation are
EXOGEAN, DOGFISH, and MARS, which all predict more
coding exons than the annotation.
Prediction tracks from the UCSC browser were generally
clustered near the EGASP entries for similar categories. At
the transcript level, the BLAT aligned REFSEQ mRNAs
(‘REFgene’) were both more sensitive than all of the
prediction methods except EXOGEAN and ACEVIEW, and
approximately 8% more specific than the best EGASP
entries. The MGC transcripts (‘MGCGene’) and the CCDS
transcripts (‘CCDSgene’) were 10% and 18% more specific at
the transcript level, but had significantly lower sensitivity
than the best EGASP method due to the incomplete nature
of these sets at the time of the workshop.
In general, the accuracy of the programs varied substantially
across test sequences, but some programs appear to behave
more consistently than others (as is reflected in the boxplots
in Figures 5-8).
Programs performed in general better in the training than in
the test sequences, the two exceptions being ACEVIEW from
category 3 and FGENESH++ from category 1 (Figure 10).
No overall trend was observed when comparing performance
between manually placed ENCODE regions and the random
ones (Figure 11). Even though, programs in category 4
performed consistently better in the random picks.
Programs performed clearly better in medium or high gene
dense regions than in regions poor in genes (Figure 12). Only
the category 6 method SPIDA had higher accuracy in regions
of low gene density.
The accuracy of the programs was also related to the level of
conservation of the genomic sequence in the mouse genome,
with programs performing generally better in the test
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Figure 9
Exon counts per gene transcript. A comparison of the number of exons per transcript and coding exons per transcript in the GENCODE annotation of
the 31 test regions and in the predictions. Blue bars show the average number of coding exons per coding transcript for each of the programs in
categories 1, 2, 3, and 4; the blue line shows this for the GENCODE annotation. The number of all exons per transcript in the GENCODE annotation is
shown with a red line. Those programs that predict non-coding exons are noted with red bars. Programs marked with an asterisk predict multiple
transcripts per gene locus.
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0
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8.12 coding exons per transcriptsequences showing stronger conservation in the mouse
genome, but the trend was not as strong as with gene density
(Figure 13).
Results by category for the CDS evaluation
Category 1: methods using any type of available information
Four prediction methods were considered in EGASP
category 1. Of these the FGENESH++ pipeline [56], the
PAIRAGON-any pipeline [57], and AUGUSTUS-any [58] are
conceptually similar. Each of these approaches uses
information from both expressed sequences and from ab
initio or de novo gene prediction strategies.
FGENESH++ and PAIRAGON-any consist of an alignment
step followed by de novo prediction in the regions where
there are not alignments. The sensitivity of these two
methods is similar for all levels of the evaluation, but
PAIRAGON-any is significantly more specific. AUGUSTUS-
any uses both the ‘hints’ discovered in its expressed
sequence (category 3) strategy and those discovered in its
dual-genome (category 4) strategy.
Both the AUGUSTUS and the PAIRAGON groups submitted
predictions in categories 1 and 3, allowing us to judge the
value of the additional information that each of the
programs used in producing the category 1 predictions.
Neither program shows a significant increase in predictive
performance in this category over their respective category 3
predictions (see below). For AUGUSTUS-any, this suggests
that its models get very little additional information from the
inclusion of the dual-genome prediction information. For
PAIRAGON-any, the category 1 prediction set included only
two transcripts not included in the category 3 prediction set
(PAIRAGON+NSCAN).
JIGSAW [59] is unlike the other three methods. It uses a
statistical combination of several sources of evidence to
create the best consensus prediction. Considering all the
evaluation measures, JIGSAW is the most accurate category
1 prediction method, although both PAIRAGON-any and
FGENESH++ are more sensitive than JIGSAW at the
transcript level. FGENESH++ and PAIRAGON-any predict
multiple transcripts per gene locus.
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Figure 10
Correlation Coefficient Accuracy for Training and Test Sequences.The correlation coefficient (CC) at the nucleotide level for CDS evaluation for
sequences EN_TRN13 and EN_PRD31 for training and test set sequences. NA, not available; because the submitters did not send their results for the
training set.
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TRAINING SET TEST SETCategory 2: single-genome ab initio methods
Three ab initio prediction methods use only the information
found in the human genome sequence. All three methods
only predict coding transcripts and are thus only considered
by the CDS evaluation. Of the three, GENEZILLA is the most
sensitive at the nucleotide and exon levels, while
AUGUSTUS-abinit is the most specific. AUGUSTUS-abinit is
consistently better than the other two at finding the start and
end of translation and is thus both more sensitive and more
specific at both the transcript and the gene level.
There are two variants of the predictions made by (the
human genome version) of the GENEMARK.hmm program
[60]. Data marked GENEMARK.hmm-A were produced and
submitted prior to the deadline and inadvertently used
unmasked genomic sequence (communication at the work-
shop by M Borodovsky). This is also the case for the
GENEZILLA predictions in the single genome category,
which were also created using unmasked sequence. There-
fore, we caution the direct comparison of GENEMARK.hmm-
A and the GENEZILLA results to the results of the other
programs, which in general used masked genomic sequence.
It is well known that gene finding programs do worse on
unmasked sequences due to the high ‘protein-coding-like’
content of repetitive elements, resulting in an increase of the
number of false positive predictions [61]. Data marked
GENEMARK.hmm-B were produced by the same human
genome version of the GENEMARK.hmm algorithm run on
the masked sequence (communication by M Borodovsky),
although this was a post-deadline submission. It is clearly
seen that the specificity values for GENEMARK.hmm are
higher when run on masked sequence due to the significant
decrease in the false positive rate.
Category 3: EST-, mRNA-, and protein-based methods
More submissions were received for category 3 than for any
of the other categories and the type of expressed sequence
information (EST, mRNA, protein sequence) varied among
http://genomebiology.com/2006/7/S1/S2 Genome Biology 2006, Volume 7, Supplement 1, Article S2 Guigó et al. S2.19
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Figure 11
Correlation Coefficient Accuracy for manually and randomly selected Sequences. The correlation coefficient (CC) at the nucleotide level for CDS
evaluation for EN_MNLp12 and EN_RNDp19 for manually and randomly selected sequences within the test set.
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MANUAL PICKS RANDOM PICKSthe methods, as did the strategy for incorporating the
information. As such, it is not surprising that the methods
have various strengths and weaknesses depending on the
details of the method. For example, ACEVIEW [52] has the
highest transcript sensitivity and predicts an average of 4.05
coding transcripts per gene locus. This is nearly twice as
many transcripts per gene compared to EXOGEAN [62],
which is nearly as sensitive (44.7% and 42.5%, respectively)
and predicts only 2.34 coding transcripts per gene locus.
ACEVIEW also has the highest coding exon sensitivity, but its
high sensitivity comes at a cost of a relatively low specificity.
For the CDS evaluation at the nucleotide level, AUGUSTUS-
EST [58] is the most sensitive program and EXOGEAN is the
most specific. There is little distinction at the nucleotide
level among most of the category 3 programs with the
exception of EXONHUNTER [63], which seems to get less
information from expressed sequences and scores
significantly lower than the other programs.
At the coding exon level, the best programs (EXOGEAN,
PAIRAGON+NSCAN_EST, and ENSEMBL) predict more
than 75% of the exons correctly, while maintaining
specificity greater than 80%. Of these three, EXOGEAN is
the most sensitive, and PAIRAGON+NSCAN_EST is the
most specific. A similar story exists at the transcript level,
where each of these 3 programs predicts more than 39% of
the coding transcripts correctly, with specificity greater than
50%. Again EXOGEAN is the most sensitive (42.5%
compared with 39.3% for PAIRAGON+NSCAN_EST and
39.8% for ENSEMBL) and PAIRAGON+NSCAN_EST is the
most specific.
At the gene level, ENSEMBL [64] is more sensitive than
PAIRAGON+NSCAN_EST (71.6% versus 69.6%) and more
specific. EXOGEAN is the most specific program at the
gene level at a specificity of 80.8% with a sensitivity of
63.2%.
Category 4: dual- or multiple-genome based methods
Six groups submitted gene structure predictions that were
assigned to the dual-genome category. ACESCAN, however,
submitted predictions only on the 13 training regions and
was, therefore, not evaluated.
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Figure 12
Correlation Coefficient Accuracy in relation to gene density. The correlation coefficient (CC) at the nucleotide level for sequences EN_PGH12,
EN_PGM11 and EN_PGL8 for high, mid and low gene density sequence sets within the test set.
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High gene density Mid gene density Low gene densityOf the dual-genome prediction programs, NSCAN [57] is
generally the most sensitive and the most specific for all
evaluation levels. The only exception is at the nucleotide level,
where AUGUSTUS-dual [58] is more sensitive (88.9% versus
85.4%) at a cost of being less specific than NSCAN (80.2%
versus 89.0%). All of the dual-genome predictors except MARS
[65] are limited to predicting one transcript per gene locus.
NSCAN is one of the most conservative of the dual-genome
gene predictors, which partly explains its high transcript and
gene specificity. It predicts approximately 90 fewer genes
than SAGA [66], approximately 110 fewer than MARS, and
almost 130 fewer than AUGUSTUS-dual. Only DOGFISH
[67], which predicts 219 genes, is more conservative.
Other predictions
Two programs submitted predictions on the test regions for
category 5 (methods predicting unusual genes, non-canonical
splicing, short intronless genes, and so on). Both GENEID-
U12 and SGP2-U12 (T. Alioto, unpublished) are optimized to
find genes that contain U12 introns (see Patel and Steitz [68]
for an in-depth review on U12 splicing).
Six programs submitted predictions that were included in
category 6 (exon only predictions). ASPIC predicted only
introns for the training regions, CSTMINER predicted
coding regions, but did not provide strand information or
splice site boundaries, DOGFISH-C-E and UNCOVER
predicted only novel exons, and AUGUSTUS-exon and
SPIDA predicted exons but they did not attempt to link them
into transcript structures.
The programs in categories 5 and 6 have very specialized and
diverse goals and cannot easily be compared to each other or
to the predictions in other categories. Their accuracy values,
however, have been computed when possible, and they are
provided in the Supplementary material.
Results for the mRNA evaluation
In the computational gene finding literature, gene predic-
tions have traditionally been evaluated using coding
transcripts only. That is, only the exonic structure of the
coding fraction of the gene or transcript is taken into
account both in the prediction and in the annotation. One
reason for this has been the difficulty of experimentally
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Figure 13
Correlation Coefficient Accuracy in relation to sequence conservation. The correlation coefficient (CC) at the nucleotide level for sequences EN_PMH7,
EN_PMM5 and EN_PML7 for high, mid and low conservation with mouse sequences only for the randomly selected sequences in the test set.
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High mouse homology Mid mouse homology Low mouse homologydetermining ‘full length’ cDNAs, which represent a full
mRNA transcript. While it is difficult to accurately clone and
sequence the 3’ UTRs of cDNA clones, it is even harder to
obtain and sequence the 5’ UTRs of a gene transcript.
Besides the limitation of existing experimental data, very
little signal information exists in the sequence of 5’ and 3’
UTRs of genes that can be statistically modeled. Therefore,
most of the computational gene finders have historically
made no attempt to predict UTRs, and instead predicted
genes from the start codon to the stop codon.
Apparently, encouraged by the announcement to explicitly
try to “replicate the GENCODE annotations”, which included
many full mRNA transcript annotations in the training set,
several programs submitted predictions of the entire exonic
structure of the mRNA molecules. FGENESH++,
PAIRAGON+NSCAN_EST, ACEVIEW, ENSEMBL,
EXOGEAN, and NSCAN programs all submitted full
transcript predictions, including coding and untranslated
(UTR) exons. We have compared these predictions with the
annotated exonic structure of the mRNA transcripts within
the GENCODE annotation. Accuracy results for the mRNA
evaluation of these programs are given in Table 6.
In general, programs performed worse when predicting the
exonic structure of the entire transcript than when predic-
ting only the coding exons. This is consistent with the fact
that the UTR sequences are less constrained than regions
coding for amino acid sequences. Note, however, that the 3’
and 5’ end of the genes are particularly difficult to delineate
experimentally. Therefore, a metric that emphasizes predic-
tion of exact exon boundaries will lead to an under-
estimation of the accuracy of the predictions. Evaluation of
the predictions at the intron level, instead of exon level,
could partially address this limitation. In any case, given
these limitations, ACEVIEW exhibits the highest accuracy of
mRNA evaluations and has similar accuracy, at least at the
nucleotide level, when considering either the entire mRNA
or the CDS. In contrast to other programs, ACEVIEW is
more specific in the entire mRNA than on the CDS. It also
has the highest sensitivity, although ENSEMBL, EXOGEAN
and PAIRAGON+NSCAN_EST are more specific.
Interpreting the results
The 44 ENCODE regions represent 30 Mb (approximately
1%) of the human genome. The 31 EGASP test regions
include 21.6 Mb and represent an even smaller fraction of
the human genome. Although this is the largest region ever
used for benchmarking automatic genome annotation, it is
not a random selection of the human genome, and, there-
fore, results obtained in them should only be extrapolated to
the whole genome with appropriate caution. The stratifica-
tion of the ENCODE regions into ‘manually’ versus ‘randomly’
selected and according to gene density and conservation
with mouse (Table 1) allows for an investigation into how
these factors affect the accuracy of gene predictions.
Figure 14a displays the accuracy of each program (average
sensitivity and specificity at the nucleotide level) in the form
of boxplots for each individual sequence in which genes were
annotated (27 of the 31 EGASP regions) and for the
collections of sequences discussed next (random versus
manual, training versus test, low, medium and high gene
density, and low, medium and high conservation with the
mouse genome). The accuracy of the programs varied
substantially across sequences (with a median value raging
from values below 0.7 (ENm011) to above 0.95 (ENr332).
Figure 14b shows similar results but on the exon level. In
what follows, we describe potential biases in the evaluation
results that can be explained by the characteristics of the raw
sequences, instead of the behavior of the prediction methods.
Training versus testing regions
We compared the predictive accuracy of each of the
programs on the set of 13 training regions to their
performance on the 31 test regions. Most of the gene
prediction programs were more accurate on the training set
compared to the test set (Figure 10). This can be partially
explained by the training set being enriched in gene dense
regions (see the section Gene rich versus gene poor regions
below; Table 1). Indeed, 11 of the 13 training regions (85%)
had a high or medium gene density, compared with 23 out of
the 31 test regions (74%).
Random versus manual regions
Within the test set, we compared the performance of each of
the gene prediction programs on the set of 12 manually
placed ENCODE regions to their performance on the set of
19 ENCODE regions chosen randomly (Figure 11). Some
programs performed better in the manual regions, while
others did on the random ones, but no overall trend could be
observed. Only programs in category 4 (dual- or multiple-
genome predictors) performed consistently better in the
random than in the manual picks. One possible explanation
for this might be that the GENCODE annotation is more
exhaustive in the regions selected manually. These regions
contain genes of interest, and some of them have been
extensively investigated. Therefore, the coverage by cDNAs -
on which the GENCODE annotation is based - is likely to be
higher in the manual than in the randomly chosen regions,
which might explain the difference in class performance.
Gene rich versus gene poor regions
We compared the performance of the prediction programs
based on the stratification of high (12 sequences), medium
(11 sequences) and low (8 sequences) gene dense regions
(see the data description in the section Description of the
sequence above). In general, all programs performed better
in regions with medium or high gene density than in regions
with low gene density (Figure 12). This reflects the low
specificity resulting from a higher rate of false positive
predictions. Interestingly, single genome ab initio gene
finders (category 2) performed the best in very gene rich
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Figure 14
Gene Prediction Accuracy for each ENCODE sequence at the nucleotide and exon levels. Boxplots showing the average sensitivity and specificity at the (a)
nucleotide level and (b) exon level for CDS evaluation of each program on every sequence of the test set. Sequences are displayed across the x-axes. Manual
picks are shown in in light blue; random picks are shown in orange. Boxplots corresponding to the overall average sensitivity and specificity at the nucleotide
level for CDS evaluation in different subsets of the ENCODE sequences are shown at the right of the graph. EN_TRN13, the set of 13 training regions, and
EN_PRD31, the set of 31 test regions, are shown in green. EN_MNLp12, the 12 manual picks in the test set, and EN_RNDp19, the 19 random picks in the
test set are shown in dark blue. EN_PGH12/EN_PGM11/EN_PGL8, the subsets of 12 high, 11 medium and 8 low gene dense sequences from the set of test
sequences, are shown in yellow. EN_PMH7/EN_PMM5/EN_PML7, the subsets of seven regions with high sequence conservation with mouse, five regions
with medium conservation, and seven regions with low conservation from random picks in the test set, are shown in red.
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(a)
(b)regions, while the programs in all other categories
performed the best in regions with an intermediate density
of genes. This is possibly due to the training of the programs
tuned to balance over- and under-prediction.
High versus low conservation with mouse regions
We also compared the performance of the prediction
programs in the randomly selected sequences with high
(seven sequences), medium (five sequences) and low (seven
sequences) conservation with mouse (see the data descrip-
tion in the section Description of the sequence above).
Programs performed generally better in sequences showing
higher conservation with mouse, but the trend was not as
strong as with gene density (Figure 13). As expected, dual
genome predictors performed better in sequences with high
mouse homology, but the trend was also observed for single
genome predictors. It is possible to speculate that genes
conserved across species are also likely to exhibit more
typical sequence characteristics, in terms of codon bias and
splice site signals, whereas fast evolving genes may have
undergone changes toward unusual sequence biases. Single
genome predictors are likely to perform better on genes
exhibiting typical features.
The experimental test of unannotated predictions
The second major goal of EGASP was to assess the complete-
ness of the GENCODE annotation. This annotation is based
on available evidence, and we cannot immediately rule out
the possibility that it misses a fraction of protein coding
genes. Indeed, many predictions submitted for EGASP did
not match any GENCODE annotated exon. Table 7 lists the
total number of unique coding and non-coding exons predic-
ted by each program, as well as the number of unannotated
exons (that is, predicted exons not overlapped by a
GENCODE annotated exon by 1 bp or more). Also listed is
the number of unannotated exons predicted in intergenic
regions. The unannotated are termed ‘wrong exons’ in the
evaluation section above. It is unclear what fraction of these
unannotated exons belong to annotated genes or are exons
of novel, unannotated genes. We have carried out an initial
investigation by comparing the unannotated exons with
transcript data obtained from the hybridization of polyA+
cytosolic RNA onto Affymetrix high-density genome tiling
microarrays covering the ENCODE regions. Details of the
technology and applications have recently been published
[69,70]. Briefly, positive hybridization probes are combined
into discrete sites of transcription, which are usually known
as TARs (transcriptionally active regions) or transfrags
(transcribed fragments). It is important to note that
identification of TARs/transfrags is based on selecting a
threshold of detection that is derived from estimates of 5%
false positive detection using a bacterial sequence spike in
controls [71]. Raising or lowering the false positive rates can
alter these thresholds. More or fewer detected regions of
transcription will likely follow from these changes.
TAR/transfrag maps corresponding to different cell lines
and conditions have been downloaded from the ENCODE
specific UCSC browser [35]. Table 7 lists the number of
predicted unannotated exons that overlap TARs/transfrags
by at least 1 bp. Overall, 44.7% of the EGASP predicted exons
overlap TARs/transfrags. Importantly, while 71% of the
annotated exons overlap TARs/transfrags, only 13% of the
unannotated exons do. This difference suggests that many of
the predicted, but not annotated, exons are false positives.
Support by TARs/transfrags, however, indicates only that
the predicted exon appears to be transcribed and, possibly,
processed into an RNA sequence. It does not allow us to
infer that the predicted exons assemble into the predicted
transcript structure, or that the transcript is a protein-
coding RNA. Therefore, to better assess the likelihood of the
predicted exonic structures, we selected a subset of the
predicted but unannotated exon pairs to be tested experi-
mentally by RT-PCR. We focused our verification efforts on
the subset of 8,634 intergenic exons (Table 7), since these
predictions could correspond to yet undetected, novel genes.
We ranked the predictions based on the predictive specificity
at the exon level for the given programs and then selected
the top 200 ranking exons. We next identified all predicted
introns (exon pairs) radiating from this set of exons. That is,
we paired each of these exons with its immediate upstream
and downstream neighbors within the same predicted
transcript. Selection of those pairs not overlapping any
GENCODE annotation resulted in 238 unique non-inclusive
exon pairs (pairs in which one of the exons was included in
an exon from another selected exon pair were discarded). Of
these pairs, 221 could be tested by RT-PCR (see Materials
and methods) in 24 tissues. All data files can be accessed
through the Supplementary material web page. Of the
assayed exon pairs, only seven (3.2%) produced a positive
result, all with perfectly predicted exon boundaries. Of the
seven validated exon pairs, three were intergenic,
presumably representing new transcribed loci, while four
extended existing gene annotations. Every positive case was
expressed in only a single tissue out of the 24 tested. This
result is comparable to that obtained for novel human genes
identified using the chicken genome as reference (expressed
on average in 3.3 tissues) [72] or for the recently described
chimeric transcripts (expressed on average in 2.5 tissues)
[73]. This result is significantly below the 7 to 8 average
positive tissues out of 12 tested found for known mammalian
genes [14,74], suggesting that the majority of yet unanno-
tated genes have a restricted pattern of expression. This also
suggests an explanation for why these transcripts have
eluded identification by experimental means until now.
The number of exon pairs (introns) tested per program, and
the number of positive verifications are given in Table 8 (see
also the Supplementary material web page for information
about the positive cases [51]). There appear to be differences
in the success rate by program, but the numbers are too
small to draw significant conclusions. Interestingly, the
S2.24 Genome Biology 2006, Volume 7, Supplement 1, Article S2 Guigó et al. http://genomebiology.com/2006/7/S1/S2
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ranking based on the specificity of the programs: 3 out of the
7 positive predictions ranked among the top 50 ranked
predictions, and 6 ranked among the 100 top ranking
predictions. This suggests that combining multiple sources
of evidence helps to identify the computational predictions
that correspond to ‘bona fide’ genes. Consistent with these
observations, TARs/transfrags overlap with about 20% of
the exons classified among the 200 top ranking ones, but
only with 13% of the intergenic predicted exons overall. Two
of the positive predictions had already been included in later
releases of the GENCODE annotation, but were unknown at
the time of experimental verification. Two are extending
‘putative’ GENCODE loci, and three could correspond to
novel genes - one being antisense to an annotated GENCODE
locus. In the GENCODE annotation, the sequence of the
RT-PCR products is passed back into the GENCODE
pipeline, where it is used as another source of transcript
sequence evidence. Future versions of GENCODE will
incorporate the validated computational predictions.
Since TAR/transfrag support has not been used to prioritize
predicted exons for experimental verification, it is possible
to investigate whether the results of the RT-PCR experi-
ments are consistent with the TAR/transfrag data, and
whether these data can be used to prioritize verification
experiments. For example, one would expect the likelihood
of RT-PCR success to be higher when the two predicted
exons to be tested are both supported by TARs/transfrags
from the same cell line and condition, suggesting that the
two exons are connected into the same RNA sequence. In
only seven of the 221 exon pairs tested were the two exons
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Table 7
Exons predicted by the programs not overlapping GENCODE annotated exons, and supported by transfrag evidence from genome
tiling microarrays
Number of  Number of 
Total number  Number of  Number of  non-annotated  Number of  intergenic 
of unique  exons overlapping  non-annotated  exons overlapping  intergenic  exons overlapping 
exons TARs/transfrags (%) exons TARs/transfrags (%) exons TARs/transfrags (%)
Category 1
AUGUSTUS-any  4,160 2,718 (65.3%) 484 74 (15.3%) 281 38 (13.5%)
FGENESH++  4,784 2,766 (57.8%) 1,071 146 (13.6%) 885 123 (13.9%)
JIGSAW  3,935 2,673 (67.9%) 206 34 (16.5%) 130 19 (14.6%)
PAIRAGON-any  4,414 3,080 (69.8%) 284 84 (29.6%) 221 68 (30.8%)
Category 2
AUGUSTUS-abinit  3,699 2,336 (63.2%) 776 175 (22.6%) 482 111 (23.0%)
GENEMARK.hmm  6,897 2,552 (37.0%) 3,796 319 (8.4%) 2,826 244 (8.6%)
GENEZILLA  3,415 1,535 (44.9%) 1,361 110 (8.1%) 970 69 (7.1%)
Category 3
ACEVIEW  8,410 5,756 (68.4%) 539 118 (21.9%) 449 106 (23.6%)
AUGUSTUS-EST  4,073 2,700 (66.3%) 439 73 (16.6%) 253 37 (14.6%)
ENSEMBL  4,505 3,094 (68.7%) 251 27 (10.8%) 187 17 (9.1%)
EXOGEAN  5,014 3,480 (69.4%) 183 21 (11.5%) 100 15 (15.0%)
EXONHUNTER  6,376 2,843 (44.6%) 2,782 257 (9.2%) 2,055 187 (9.1%)
PAIRAGON+NSCAN_EST  4,404 3,073 (69.8%) 284 84 (29.6%) 221 68 (30.8%)
Category 4
AUGUSTUS-dual  4,024 2,588 (64.3%) 629 114 (18.1%) 364 65 (17.9%)
DOGFISH  3,194 2,290 (71.7%) 267 115 (43.1%) 225 99 (44.0%)
MARS  4,623 2,801 (60.6%) 948 161 (17.0%) 528 89 (16.9%)
NSCAN  3,996 2,686 (67.2%) 500 133 (26.6%) 342 92 (26.9%)
SAGA  2,115 1,147 (54.2%) 564 36 (6.4%) 433 26 (6.0%)
All unique exons (18 progs) 26,818 12,001 (44.7%) 12,025 1,563 (13.0%) 8,634 1,163 (13.5%)supported by TARs/transfrags from the same cell line.
Interestingly, three of these cases were positive by RT-PCR.
This is a success rate of 43%, compared with 4 successful
RT-PCRs out of 214 exons not having consistent transfrag
support (less than 2% success rate). While the numbers are
too small for significant conclusions, the trend is quite
striking: consistent transfrag support of computational
predictions is strongly indicative of RT-PCR success.
Conversely, the reasons why exon pairs fail RT-PCR
verification when supported by consistent transcription
evidence from the same cell line and condition are multiple.
Depending on the primers chosen, for instance, wrong
prediction of the exon boundaries, even by a small offset,
may lead to failed RT-PCR amplification. Moreover,
TAR/transfrag maps have been obtained from cell lines
different from the tissues used for RT-PCR. Given the
extremely restricted expression pattern that these novel
transcripts appear to show, transcripts expressed in one
given cell line may not be expressed in any of the 24 tissues
analyzed. In this regard, it is interesting to note that the four
negative RT-PCR exon pairs cluster into a single locus, and
even share some sequence (see the Supplementary material
web page), and, therefore, may represent the same
transcript, while the three other transfrag-supported
positive RT-PCR exon pairs correspond to three distinct loci
mapped to three different ENCODE regions.
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Table 8
Number of exon pairs (introns) tested per program, and the number of positive verifications
Number of  Number of  % of positive 
Number of  tested exon pairs  positive RT-PCR pairs  RT-PCR pairs 
Number of  positive RT-PCR  suported by TARs/ supported by TARs/ supported by 
tested exon  exon pairs and  transfrags and % over  transfrags and % over  TARs/transfrags 
pairs  % over tested  tested pairs supported pairs over positive 
Category 1
AUGUSTUS-any  31 2 (6.5%) 3 (9.7%) 1 (33.3%) 50.0%
FGENESH++  119 3 (2.5%) 3 (2.5%) 1 (33.3%) 33.3%
JIGSAW  19 2 (10.5%) 3 (15.8%) 1 (33.3%) 50.0%
PAIRAGON-any  1 0 (0.0%) 0 (0.0%) 0 (0.0%) 0.0%
Category 2
AUGUSTUS-abinit  29 2 (6.9%) 2 (6.9%) 1 (50.0%) 50.0%
GENEMARK.hmm  99 1 (1.0%) 3 (3.0%) 1 (33.3%) 100.0%
GENEZILLA  34 2 (5.9%) 1 (2.9%) 0 (0.0%) 0.0%
Category 3
ACEVIEW  13 4 (30.8%) 2 (15.4%) 2 (100.0%) 50.0%
AUGUSTUS-EST  31 2 (6.5%) 3 (9.7%) 1 (33.3%) 50.0%
ENSEMBL  10 1 (10.0%) 2 (20.0%) 1 (50.0%) 100.0%
EXOGEAN  18 1 (5.6%) 3 (16.7%) 1 (33.3%) 100.0%
EXONHUNTER  23 1 (4.3%) 2 (8.7%) 0 (0.0%) 0.0%
PAIRAGON+NSCAN_EST  1 0 (0.0%) 0 (0.0%) 0 (0.0%) 0.0%
Category 4
AUGUSTUS-dual  26 1 (3.8%) 3 (11.5%) 1 (33.3%) 100.0%
DOGFISH  11 2 (18.2%) 1 (9.1%) 1 (100.0%) 50.0%
MARS  47 7 (14.9%) 5 (10.6%) 3 (60.0%) 42.9%
NSCAN  26 0 (0.0%) 2 (7.7%) 0 (0.0%) 0.0%
SAGA  9 0 (0.0%) 1 (11.1%) 0 (0.0%) 0.0%
All unique exon pairs 238 7 (2.9%) 7 (2.9%) 3 (42.9%) 42.9%
The percentage of success has been computed in the table on the 238 selected exon pairs. For technical reasons, only 221 of them could be tested by
RT-PCR. In the text the percentages are given with respect to this number.Discussion
The unfolding of the instructions encoded in the DNA
sequence is initiated by the transcription of DNA to RNA,
and the subsequent processing of the primary transcript to
functional RNA sequences. According to the central dogma,
most of these processed RNAs correspond to mRNAs that
are eventually translated to proteins. Despite the fact that
the identification of the protein-coding mRNAs (or genes) is
essential for our understanding of how the genome sequence
translates into biological phenomena, uncertainty still
remains with respect to the set of human genes. The lack of
an accurate and complete gene catalogue undermines the
impact of the genome sequence on human biology and bio-
medical research. Experimental determination of expressed
mRNA sequences and computational mapping of this
sequence onto the sequence of the genome constitutes the
most reliable approach to identify the exonic structure, and
chromosomal location, of protein-coding genes. However,
this approach has limitations. First, it is unclear what
fraction of low and specifically expressed transcripts can be
effectively sequenced, and high throughput mRNA sequen-
cing often leads to only partial sequences. Second,
computational mapping of mRNA to genomic sequences is
not trivial, and it is complicated by fragmentary mRNA
sequences, sequencing errors, sequence polymorphism, and
the highly repetitive nature of the human genome. More-
over, the high pseudogene content of the human genome,
and the presence of small exons, leads to uncertain or
incorrect mapping of exon boundaries. Therefore, sub-
stantial manual intervention is required to delineate an
accurate protein coding gene map from the available mRNA
sequence data.
We organized EGASP as a community experiment with the
goal of assessing the ability of computational methods to
automatically reproduce the accurate protein-coding gene
map produced by a team of expert human curators. Such a
map [33], subsequently verified experimentally, has been
obtained for only 1% of the human genome selected by the
ENCODE project [30]. Scaling the map to the entire human
genome will require substantial additional resources, and it
will enormously benefit from improved computational
strategies for gene finding. With its focus on this 1% of the
human genome, EGASP has indeed demonstrated progress
in the performance of newly developed computational gene
finding pipelines, with accuracies of about 80% at the coding
exon level for both sensitivity and specificity, and of nearly
90% at the coding nucleotide level (Table 4). However, the
success of these metrics is significantly tempered by the
relatively low numbers of coding transcripts that are predicted
correctly. Programs relying on mRNA and protein sequences
were the most accurate in reproducing the manually curated
annotation. This is not unexpected, and, to some extent,
circular, since the manually curated annotation relies on
mRNA and protein sequences as well. Notably, however,
programs based on sequence comparisons across two or
more genomes - which do not use information from known
mRNA or protein sequences - also exhibited impressive
accuracy at the nucleotide and exon levels (Table 6). Dual
genome prediction programs, however, were significantly
less accurate at finding complete genes than the expressed
sequence based methods. Finally, with few exceptions, all of
the methods struggled to predict correctly the non-coding
exons of transcripts. Indeed, UTRs are often predicted as
mere extensions of first and terminal exons, if predicted at
all. Thus, while the computational methods are quite reliable
in predicting the protein coding components of transcripts,
they have difficulties in linking them into transcript
structures. Indeed, the most accurate programs were only
able to correctly predict about 40% of the annotated
transcripts, meaning the correct prediction of all of the
exons constituting a transcript (Table 5). The results of
coding gene predictions were more encouraging. For up to
80% of human genes the exact structure of the coding part,
including all the splice junctions and start/stop codons,
could be predicted correctly in at least one transcript.
Contributing to the difficulty is the unexpected complexity of
the protein coding loci in higher eukaryotic genomes. Indeed,
as revealed in the GENCODE annotation, most protein
coding loci appear to encode a mixture of coding and non-
coding transcripts, sharing part of their sequence. Additional
transcriptional activity, including chimeric, overlapping and
antisense transcripts, transcripts within introns, and other
transcriptional phenomena, appear to be less exceptional
than had been previously suspected. Thus, the model of a
eukaryotic gene currently implicit in most computational
methods is too simple to capture this complexity, leading to
relatively poor prediction performance.
The second goal of EGASP was to assess the completeness of
the manual/computational/experimental GENCODE annota-
tion. This annotation is based on available evidence, and
thus may miss some protein coding genes and exons.
Indeed, in EGASP, computational methods predict many
exons and transcripts that are not included in the
GENCODE annotation (Table 7), a trend accentuated in ab
initio and comparative gene finders, which do not rely on
available evidence from transcript sequences. While we were
not able to confirm experimentally the bulk of these
predictions and they are likely to be false positives, some
might be real.
To assess what fraction of the predicted exons unannotated
in GENCODE could correspond to novel genes, we
prioritized - based on the reliability of the programs predic-
ting them - a subset of intergenic predicted exon pairs, and
attempted to experimentally verify them by RT-PCR in 24
human tissues. Only 3.2% of these pairs tested positive, a
result consistent with most of the computational predictions
outside of GENCODE being false positives. All verified cases
tested positive in only one tissue among the 24 tested,
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hemphasizing the extremely restricted expression patterns of
these novel, unannotated exons. Since many more tissues
and cell lines exist, it cannot be ruled out that some other
predictions could also be positive in other tissues. Support
for a larger fraction of predictions corresponding to real
exons comes from the observation that 13% of these predic-
tions overlap sites of transcription (or TARs/transfrags) as
detected by genome tiling experiments. Interestingly, the
success rate of RT-PCR was much higher (at least 40%) for
those few tested exon pairs that both overlapped TARs/
transfrags and were detected in the same cell line and con-
dition. Thus, consistent TAR/transfrag support is strongly
indicative of an underlying transcript, including exons
predicted to be connected. In total, about 100 unannotated
predicted exons in EGASP are consistently supported by
TARs/transfrags, and are, therefore, likely to belong to
transcribed RNAs. In summary, a non-negligible fraction of
unannotated exons predicted in EGASP have some evidence
of transcription (not necessarily associated with protein
coding), but only a small fraction of the predicted structures
connecting exons could be verified experimentally here.
In this regard, the EGASP experiment seems to indicate
that the GENCODE annotation of protein coding genes is
quite complete, although it is still unclear what fraction of
all the alternative transcript diversity of gene loci is
captured by GENCODE. EGASP was also useful in helping
to identify the software tools that can contribute to reduce
the amount of human intervention required to delineate the
GENCODE annotation. Programs accelerating and improv-
ing the mapping of cDNA sequences (partial or complete)
into the genome sequence could be particularly useful
towards that end.
Overall, we believe that the EGASP project has given a fair
assessment of the state-of-the-art of gene prediction in
human DNA. This will allow biologists to interpret better the
annotations presented to them in public genome databases
such as GenBank, the UCSC browser, ENSEMBL and others.
It has also clearly shown that we are still far from being able
to computationally predict human gene structures with total
accuracy from the DNA sequence alone. Furthermore, while
we believe the experiment has shown that only very few
protein-coding human genes seem to missing from the
annotations, the exact protein sequences are annotated for
roughly over 50% of the sequences. Getting a complete
protein sequence correct is also made difficult by the
existence of many splice forms, mis-assembled cDNAs and
additional contamination in cDNA/EST sequences in the
public databases. Each can lead to various spurious protein
sequence annotations. Unfortunately, there are very few
processes in place to remove erroneous sequences and
annotations from the public databases, so it will still take
some time to get a better picture of exact gene structures. It
has to be noted that the human genome and its annotation
for protein coding genes are still works in progress.
Another class of genes, non-protein coding transcripts,
which were not generally considered by EGASP, are thought
to be especially difficult to predict. These genes, such as
those that encode miRNAs and snoRNAs, were not
addressed in this experiment; nevertheless, they seem to
play a very important role in physiological processes such as
development and disease.
One of the most difficult problems in gene prediction
accuracy assessment is the definition of a reference set
against which to evaluate. Ultimately, this reference set
should be ‘unknown’ to the prediction teams. In EGASP, the
delayed publication of the GENCODE annotations partially
achieved this goal, although a significant amount of the
annotation information was known from previously
submitted cDNA and EST sequences to public databases
such as ENSEMBL or Genbank. This is slightly different to
GASP1 [27], where novel cDNA sequences had been
withheld before the experiment. Additionally, it may be
optimal if each group used the same auxiliary data for their
predictions. One suggestion would be to ‘freeze’ databases of
auxiliary data and allow only the inclusion in the predictions
of these frozen databases, so that progress in these
assessment experiments can be measured independently of
growing experimental data.
Furthermore, while our assessments have started to evaluate
gene annotations on the transcript level, better and
additional evaluation methods for evaluating UTRs are
needed. One suggestion would be to evaluate the transcript
performance at the intron level (similar to the exon
evaluation above). This measure would exclude the
beginning and end of a gene, two coordinates that are
considered the most difficult to obtain experimentally, but
would include non-coding introns that are determined by
their splice sites.
One of the major benefits of this kind of experiment is that it
allows prediction teams to measure their programs and
methods against each other, to learn from their failures, and,
as a community, to identify the open and difficult questions
in this area of research.
Materials and methods
Submitted predictions
Files submitted to the EGASP server were validated to
conform to the GTF specifications [33] and the use of
standard annotation features such as ‘exon’, ‘CDS’, ‘stop
codon’ and ‘start codon’. Submissions not conforming to this
format were rejected, although the participants were allowed
to fix prediction files accordingly and to resubmit to the
server (Figure 1) [47]. Submissions were clipped to the
ENCODE region sequence boundaries. The clipping criteria
were the following: ( feature_start < 1 and feature_end >= 1
then feature_start == 1 ) and ( feature_end > sequence_end
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sequence_end ); while those records where ( feature_end < 1
or feature_start > sequence_end ) were removed from the
GENCODE annotation and the submitted predictions before
performing the evaluations.
Evaluations
We used different programs to obtain accuracy values at
nucleotide, exon, gene/transcript and clustered transcripts.
These programs included software developed by the authors
at IMIM and at the EBI. We also used the Eval package [75].
We confirmed the results obtained with the evaluation
programs by comparison. The programs can be downloaded,
along with a small description on how to use them, from the
Supplementary material web page [51].
When comparing annotations against the predictions for
each individual sequence in the test sets for the boxplots,
sequences that contained no feature annotations either in
the annotations or in the predictions were excluded from the
analysis for the boxplots. This did not happen when the
numbers were computed globally for the sequences. We
considered the following sequence sets build up by
concatenating (without overlap) the coordinates of different
sequence annotation and prediction sets: EN_TRN13, all
training set sequences (13 sequences); EN_PRD31, all
evaluation set sequences (31 sequences); EN_MNLp12,
evaluation set sequences, manual picks (12 sequences);
EN_RNDp19, evaluation set sequences, random picks (19
sequences); EN_PGH12/EN_PGM11/EN_PGL8, all the
sequences of the test set were collected into three sequence
sets based on their gene density into three sequence sets, for
high, medium and low densities (12, 11 and 8 sequences,
respectively); EN_PMH7/EN_PMM5/ENPML7, in this case,
the random sequences from the evaluation set were
considered, depending on their sequence conservation with
mouse, into three sequences, for high, medium and low
conservation (7, 5 and 7 sequences, respectively). See the
Supplementary materials web page for the complete set of
results on all sequences and sequence sets [51].
The box-and-whisker plots [76] (simply ‘boxplots’) describe
graphically how the data being analyzed are distributed. The
horizontal line within the box shows the median value of the
data set, while the top and the bottom of the box correspond to
the third and first quartiles, respectively; therefore, the box
represents the interquartile range (IQR). The whiskers
represent the range of the data and show a maximum and a
minimum, which are based on 1.5 times the length of the IQR.
The notches centered on the median correspond to the 5%
interval of confidence for this median (median ± 1.57 · IQR/√n,
as defined in R [77]).
RT-PCR
Primers mapping in the two predicted exons spanning the
exon junction to be tested were designed using Primer3 [78]
with the following parameters: 18 ≤ primer size ≤ 27, optimal
size = 20, 57°C ≤ primer Tm ≤ 63°C, optimal Tm = 60°C,
20% ≤ primer GC percentage ≤ 80%. Similar amounts of 24
human cDNAs (brain, heart, kidney, spleen, liver, colon,
small intestine, muscle, lung, stomach, testis, placenta, skin,
peripheral blood lymphocytes, bone marrow, fetal brain,
fetal liver, fetal kidney, fetal heart, fetal lung, thymus,
pancreas, mammary glands, prostate, final dilution 1,000·)
were mixed with JumpStart REDTaq ReadyMix (Sigma-
Aldrich, St. Louis, MO, USA) and 4 ng/µl primers (Sigma-
Genosys, Cambridge, U.K.) with a BioMek 2000 robot
(Beckman, Fullerton, CA, USA) as described and modified
[14,79,80]. The 10 first cycles of PCR amplification were
performed with a touchdown annealing temperature
decreasing from 60°C to 50°C; the annealing temperature of
the next 30 cycles was 50°C. Amplimers were separated on
‘Ready to Run’ precast gels (Amersham Pharmacia,
Sunnyvale, CA, USA) and sequenced. We tested 221 exon
pairs out of the 238 exon pairs with an exon ranked in the
top 200. The remaining 17 exon pairs were not
experimentally evaluated because either the targeted
amplimer was too small (8 cases) or one of the exons was too
short to allow us to design a primer (9 cases).
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